Nipharmin: a new antibacterial scaffold and biological applications

CBIOS PI Patricia Rijo

From 2018 to 2019

Description

The  Nipharmin aim is to increase the potency of Nipharmins and to develop Nipharmin-based antibacterial technologies. In this context, the synthesis of new derivatives and further studies for understanding their mechanism of action are necessary. We formed a multidisciplinary team to develop this new family of antibacterials and to investigate their potential in biotechnological applications.

Partners

1- Tampere University of Technology, Lab. of Chemistry and Bioengineering, Finland (coordenator); 
2- National Institute of Health, Portugal
3- Tampere University of Technology, BioMediTech, Lab. of Biosystems Dynamics, Finland;
4- Tampere University of Technology, BioMediTech, Biomaterials Group, Finland;
5 - COFAC/CBIOS

Funding

Jane ja Aatos Erkon Säätiö (Helsinki, FI)